Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted delivery to legumain-expressing cells

Targeted delivery to legumain-expressing cells

US Patent 7608591 · Granted Oct 27, 2009

Estimated economic value: $4,010,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immune-stimulating soluble doxorubicin-conjugated complex2022
Preparation and use of molecular site targeted and activated kinase inhibitor2021
Biological complexes and methods for using same2020
Resonance Raman spectroscopy analyzer instrument for biomolecules in tissues and2019
Legumain activated doxorubicin derivative as well as preparation method and appl2018
Use of a vegetable drug composition in the manufacturing of pharmaceutical prepa2015
Combined methods for tumor coagulation and tumor treatment2010
Targeted thrombosis2008
Targeted thrombosis2008
Combined methods and compositions for coagulation and tumor treatment2004
Photon-mediated introduction of biological materials into cells and/or cellular 2002
Methods and compositions for the specific coagulation of vasculature2000